Priority Date: 14.03.13 (US 201361783437P)

COMBINATION OF DIRECT ACTING ANTIVIRAL AGENTS AND RIBAVIRIN FOR TREATING HCV PATIENTS

  • Application ID: EP14725812
  • Status: The patent has been granted

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
3 offices
active in Legal Services
Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Mewburn Ellis LLP is specialized in A61. Modiano & Partners is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 14.03.2013 - Priority Date (US 201361783437P)
  • 25.09.2014 - Publication A1 (WO2014152635)
  • 20.01.2016 - Publication A1 (EP2968302)
  • 06.09.2017 - Publication B1 (EP2968302)
  • 13.02.2019 - Publication B9 (EP2968302)